ReviewDiseases (Basel, Switzerland)2018
Prevention of Progression in Myopia: A Systematic Review.
Review in Diseases (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 51 citations in OpenAlex.
- Low-level red-light therapy for myopia control in children: A systematic review and meta-analysis.Clinics (Sao Paulo, Brazil) · 2024Pooled it
- Orthokeratology lens-relatedThe Journal of international medical research · 2021Pooled it
- Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.Japanese journal of ophthalmology · 2021Trial
- More sun, less myopia: validating CUVAF as a biomarker for outdoor exposure in a cohort of Spanish schoolchildren.Frontiers in medicine · 2026Article
- Clinical spectrum and prevalence associations of chorioretinal damage in high myopia: a retrospective cross-sectional analysis.Frontiers in medicine · 2026Article
- Standardized Corneal Topography-Driven AI for Orthokeratology Fitting: A Hybrid Deep/Machine Learning Approach With Enhanced Generalizability.Translational vision science & technology · 2025Article
- Parental behavior and near screen use in childhood: a route to reduce screen induced myopia.Frontiers in public health · 2025Article
- Comparison of the performance of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL) spectacles.BMJ paediatrics open · 2024Article
- Could Children's Myopization Have Been Avoided during the Pandemic Confinement? The Conjunctival Ultraviolet Autofluorescence (CUVAF) Biomarker as an Answer.Biomedicines · 2024Article
- Conjunctival ultraviolet autofluorescence as a biomarker of outdoor time in myopic children.Frontiers in medicine · 2024Article
- Topical Application of Bunazosin Hydrochloride Suppresses Myopia Progression With an Increase in Choroidal Blood Perfusion.Investigative ophthalmology & visual science · 2023Article
- Influence of overnight orthokeratology on tear film and meibomian glands in myopic children: a prospective study.BMC ophthalmology · 2023Article
- Piperidine Derivatives: Recent Advances in Synthesis and Pharmacological Applications.International journal of molecular sciences · 2023Review
- Prevalence of myopia in school-age children in Ethiopia: A systematic review and meta-analysis.SAGE open medicine · 2023Review
- Article
- Axial length growth difference between eyes after monocular laser refractive surgery: eight patients who underwent myopic laser ablation for both eyes at intervals of several years.BMC ophthalmology · 2022Article
- Evaluation of retinal vascular density and related factors in youth myopia without maculopathy using OCTA.Scientific reports · 2021Article
- Review on current concepts of myopia and its control strategies.International journal of ophthalmology · 2021Review
- The Impact of Overnight Orthokeratology on Accommodative Response in Myopic Subjects.Journal of clinical medicine · 2020Article
- Atropine Differentially Modulates ECM Production by Ocular Fibroblasts, and Its Ocular Surface Toxicity Is Blunted by Colostrum.Biomedicines · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The prevalence of myopia has increased worldwide in recent decades and now is endemic over the entire industrial world. This increase is mainly caused by changes in lifestyle and behavior. In particular, the amount of outdoor activities and near work would display an important role in the pathogenesis of the disease. Several strategies have been reported as effective. Spectacles and contact lenses have shown only slight results in the prevention of myopia and similarly ortokerathology should not be considered as a first-line strategy, given the high risk of infectious keratitis and the relatively low compliance for the patients. Thus, to date, atropine ophthalmic drops seem to be the most effective treatment for slowing the progression of myopia, although the exact mechanism of the effect of treatment is still uncertain. In particular, low-dose atropine (0.01%) was proven to be an effective and safe treatment in the long term due to the lowest rebound effect with negligible side effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.